Mumbai, Feb. 5 -- Revenue from operations increased 16.96% YoY to Rs 5,269.1 crore during thr quarter.

Profit before tax (PBT) jumped 27.94% to Rs 1,184.1 crore in Q3 FY25 compared with Rs 925.5 crore in Q3 FY24.

EBITDA for the quarter was Rs 1387.6 crore, up 26% YoY. EBITDA margin for the quarter stood at 26.3%, which is an improvement of 180 bps on a YoY basis.

Research & Development (R&D) investments for the quarter stood at Rs 503.1 crore in Q3 FY25, which represented 9.5% of revenues. Additionally, organic capital expenditures (Capex) stood at Rs 290.7 crore in Q3 FY25.

In terms of segment revenue, India formulations business grew by 5% YoY to Rs 1,498.2 crore.

Revenue from US Formulation business stood at Rs 2,409.6 crore in Q3...